---
title: 'Vice President, US Marketing at SpringWorks Therapeutics'
canonical: 'https://feeny.ai/job/vice-president-us-marketing-springworks-therapeutics-boston-ma-qzb38343hnwm'
type: 'job'
last_seen: '2026-09-13'
---

# Vice President, US Marketing at SpringWorks Therapeutics

- **Company:** SpringWorks Therapeutics
- **Location:** / Boston MA, United States
- **Work type:** hybrid
- **Posted:** 2026-08-04
- **Last confirmed live:** 2026-09-13
- **Apply:** https://springworkstx.com/careers/view-opportunities/?gh_jid=6134014004

## Job description

About SpringWorks Therapeutics:

SpringWorks Therapeutics, a healthcare company of Merck KGaA, Darmstadt, Germany, is a commercial-stage biopharmaceutical company dedicated to improving the lives of patients with rare tumors.

We developed and are commercializing the first and only FDA and EC approved medicine for adults with desmoid tumors and the first and only FDA and EC approved medicine for both adults and children with neurofibromatosis type 1 associated plexiform neurofibromas (NF1-PN).

At SpringWorks, we are committed to finding answers people with rare tumors need. We thrive in an atmosphere of passion and tenacity, fueled by the excitement of the possibilities science may unlock and driven to work with urgency because of the importance of our work. We value authenticity because diverse backgrounds, cultures, styles and abilities can only help us find the answers that people with rare tumors are looking for.

Your Role:

This role is accountable for leading the US Marketing Strategy and delivering the US P&L. Reporting to the SVP and Head of Rare Tumor Franchise, N.A., this role will be an integral member of the US Commercial Leadership Team who will help set the direction, culture, and focus for the Commercial Organization and support key strategic decisions. This individual is accountable for managing the annual US revenue and operating plans and securing investments to achieve strong performance and ambitious growth targets for inline and launch brands

This leader will champion the Company as a leader in Rare Diseases by establishing strong relationships with patient, advocacy, and clinician communities, as well as promoting the Company as partner of choice with major stakeholders. The role will serve as the internal subject matter expert regarding emerging trends in the US healthcare ecosystem, with a keen eye on its evolution and impact on rare disease and oncology management. The role will drive prioritized focus towards patient identification as well as removal of barriers and enablement of access to care.

Location Classification – Hybrid: ​

This role will be required to work onsite 3 days a week (Tuesday through Thursday), or more depending on business needs. #LI-Hybrid

Essential Duties and Responsibilities:

- Provides subject matter expertise & thought leadership and supports the SVP and Head of Rate Tumors Franchise, NA with decision-making on critical business challenges and opportunities shaping the commercial business and briefs executive management on relevant US market developments to inform corporate strategy and development.
- Drives the vision, design, and development of US Marketing capabilities, including roles, accountabilities, and systems, and ensures marketing function is scaled appropriately and offers insights and visibility on cross-functional capability needs.
- Provides a clear vision for the US Commercial Organization for efforts related to marketing and brand management by driving engagement and alignment across business partners in the US, including Commercial sub-teams, Medical, Supply Chain, Corporate Affairs, Legal and Compliance, Regulatory, and other relevant stakeholders to achieve alignment on strategy and plans.
- Shapes launch planning excellence and go-to-market strategies for the US. Serves as a subject matter expert and advisor on US product label development and competitive positioning of rare disease and oncology products.
- Hires, mentors and develops talent in alignment with business needs and succession goals for Commercial and the broader Company, championing a learning and teaching environment.
- Ensures US Commercial strategy reflects the voice of US patients and customers through oversight of insights and strategy development, working directly with functions to develop and maintain strong partnerships with key healthcare stakeholders
- Manages the US P&L, including growth and stability of revenue, delivering the monthly and annual financial goals, and continuously evaluating scenarios and opportunities to improve margin and profitability.
- Partners as needed with global teams and represents the US on BD/in licensing opportunities, and around LCM strategies.
- Perform other duties and responsibilities as assigned.

Role Requirements:

- Education:
- Bachelor's degree (business or related disciplines)
- MBA or other advanced degree preferred
- Minimum of 10+ years of experience within the pharmaceutical or biotechnology industries
- Minimum of 7+ related experience in leadership roles in marketing, sales and other commercial functions with experience in brand leadership, in-line marketing, specialty marketing, and P&L
- 5+ years people leadership experience with 1 year managing multiple functions
- Field experience a plus
- Recent US launch experience in rare disease and/or oncology strongly preferred
- Experience in managing commercial partnerships and co-promotions
- Demonstrated track record of successfully managing and developing teams in sales, marketing and related commercial functions
- Strong matrix leadership
- Strong general management
- Recent experience leading teams and self in high growth, fast paced, and start-up like environments
- Refined executive presentation skills
- Excellent ability to engage, influence and navigate senior and complex stakeholders
- Strong ability to manage multiple stakeholders to achieve shared objectives
- Strong ability to motivate and develop team
- Proactive with preference for advising and coaching colleagues
- Agile in an evolving environment
- Innovative mindset to do things creatively and differently
- Resilient with the ability to influence and deliver in an ambiguous environment
- Strong learning agility
- Strategically minded, operationally excellent
- 50% Travel Required

Compensation and Benefits: The expected salary range for this position is $269,600.00 - $370,700.00. Actual pay will be determined based on experience, qualifications, location, and other job-related factors permitted by law. A discretionary annual bonus may be available based on individual and Company performance. We offer best-in-class benefits for our team of SpringWorkers who work with urgency on behalf of patients suffering from devastating diseases. Interested in learning more, review additional information here [Benefits](https://springworkstx.com/careers/benefits/).

EEO Statement: SpringWorks maintains an EEO Policy providing for equitable opportunities for employment and conditions of employment to all employees and applicants regardless of actual or perceived sex (including pregnancy, childbirth, breastfeeding or related medical conditions), gender, gender identity or gender expression, sexual orientation, partnership status, marital status, familial status, pregnancy status, race, color, national origin, ancestry, caste, religion, religious creed, age, alienage or citizenship status, veteran status, military status, physical or mental disability, past or present history of mental disorder, medical condition, AIDS/HIV status, sickle cell or hemoglobin C trait, genetic predisposition, genetic information, protected medical leaves, victims of domestic violence, stalking, or sex offense, political affiliation and any and all other characteristics or categories protected by applicable federal, state or local laws. SpringWorks treats all employees and applicants fairly in the selection process (and in other personnel activities) by giving all employees and applicants the same opportunities for employment. SpringWorks’ Equal Employment Opportunity Policy is intended to ensure that there are no barriers that would prevent members of a protected group from a fair and equitable opportunity to be hired, promoted, or to otherwise take advantage of employment opportunities.

This Equal Employment Opportunity Policy applies to all aspects of employment, including, without limitation, recruitment, hiring, placement, job assignment, promotion, termination, transfer, leaves of absence, compensation, discipline, and access to benefits and training. Any violation of this Policy will result in disciplinary action up to and including termination of employment.

Privacy: Upon submission of this form I understand that SpringWorks Therapeutics is based in the United States and personal data submitted in the form will be transferred and accessed in the U.S.. Information about SpringWorks Therapeutics’ privacy practices can be found at https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fspringworkstx.com%2fprivacy-policy%2f&c=E,1,BD35FHgy1RxvzeWax2mV0qEVg3OfnWVnH9UAE_kbR4Qxe6-WmuH6GscSqesgEvL7QgHjcDXo0uWQw6MBxJlqRq-wDoY16zjPmHPK8_nUDRgAPA,,&typo=1[springworkstx.com](https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fspringworkstx.com&c=E,1,6BmxztI3ctECzNQOe0UHV03yZx9j-Yq5R4PdnIqHiqfxyIU-FpKGq0H-mC5XKvYyi0lXTCDw1loelZS00J9qTEoJQkWo0eiczLkTiNiTUDACDyt_&typo=1&ancr_add=1)).

## About SpringWorks Therapeutics

## Company Overview
- **One-liner**: SpringWorks Therapeutics is a commercial-stage biopharmaceutical company dedicated to unlocking the full potential of targeted oncology for patients with rare tumors.
- **Entity Type**: Public (NASDAQ: SWTX) – acquired by Merck KGaA, Darmstadt, Germany, in April 2025 for $3.9B
- **Headquarters**: Stamford, Connecticut, United States
- **Founded**: 2017
- **Founders**: Not publicly available (spun out from Pfizer in 2017)

## Core Business
- **Primary industry/industries**: Biotechnology – targeted oncology, rare diseases
- **Target customers**: B2B (healthcare providers, hospitals, academic centers) and B2C (patients, patient advocacy groups)
- **Mission or purpose statement**: “Improving the lives of patients with rare tumors” by waging science with tenacity and urgency [springworkstx.com](https://springworkstx.com/who-we-are/)

## Products & Services
- **OGSIVEO® (nirogacestat)**: First and only FDA- and EC-approved gamma secretase inhibitor for adults with progressing desmoid tumors. Also being studied in multiple myeloma, ovarian granulosa cell tumors, and pediatric desmoid tumors. [springworkstx.com](https://springworkstx.com/pipeline/)
- **EZMEKLY® (mirdametinib)**: First and only FDA- and EC-approved MEK inhibitor for adult and pediatric patients (2 years+) with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN). Also in Phase 2 for pediatric low-grade gliomas. [springworkstx.com](https://springworkstx.com/pipeline/)
- **SW-682 (TEAD inhibitor)**: Novel small molecule in preclinical development for biomarker-defined solid tumors driven by Hippo pathway mutations. [springworkstx.com](https://springworkstx.com/pipeline/)
- **SW-3431 (PP2A activator)**: First-in-class small molecule activator of specific PP2A complexes in preclinical development for rare uterine cancers. [springworkstx.com](https://springworkstx.com/pipeline/)

## Market Standing
- **Valuation/Market Cap**: $2.3B (as of acquisition by Merck KGaA on April 28, 2025, for $3.9B) [linkedin.com](https://www.linkedin.com/company/springworks-therapeutics)
- **Key Metric**: Annual Revenue $191.6M (2024) / Total Funding raised $1.015B (including Series A, B, and post-IPO equity) [linkedin.com](https://www.linkedin.com/company/springworks-therapeutics)
- **Notable Investors/Partners**: Perceptive Advisors (led Series B), GSK, Janssen, Pfizer, Regeneron (collaborations), Children’s Oncology Group, St. Jude Children’s Research Hospital [springworkstx.com](https://springworkstx.com/pipeline/)
- **Growth Signals**: Two approved products in both U.S. and EU; commercial-stage with $191.6M revenue; 302 employees (down 2.8% YoY due to acquisition integration); operating in 5 countries (U.S., Germany, Switzerland, Italy, UK); pipeline of 4+ programs in Phase 1/2 and preclinical [linkedin.com](https://www.linkedin.com/company/springworks-therapeutics)

## Competitive Advantages
- **First-to-market in rare tumor niches**: Only approved therapy for desmoid tumors (OGSIVEO) and first approved for NF1-PN in both adults and children (EZMEKLY).
- **Deep pipeline of targeted therapies** covering both rare and genetically defined cancers, with multiple collaborations with top pharma and academic centers.
- **Parent company support**: Now part of Merck KGaA, providing global commercial infrastructure, R&D resources, and financial stability.
- **Tenacious culture**: Emphasizes “Care Hard, Ambition Without Ego, Think Deeply Act Quickly, Good Enough is Never Enough, In It Together” – a strong, mission-driven ethos [springworkstx.com](https://springworkstx.com/careers/).

## Strategic Focus
- **Continue to maximize OGSIVEO and EZMEKLY** in existing and new geographies (EU approval just granted in 2025).
- **Expand pipeline into earlier-stage, biomarker-defined cancers** (Hippo mutant tumors, PP2A-driven uterine cancers) and combination therapies (BCMA-targeting agents in multiple myeloma).
- **Leverage Merck KGaA’s global reach** to accelerate clinical development and commercialization of pipeline assets.
- **Invest in pediatric indications** (desmoid tumors, low-grade gliomas) to address high unmet need.

## Why Work Here
- **Mission-driven impact**: Directly improve lives of patients with rare tumors – “Change the lives of patients” and “Help launch groundbreaking therapies” are core promises [springworkstx.com](https://springworkstx.com/careers/).
- **Culture of tenacity and collaboration**: Values include “Care Hard” and “Ambition Without Ego” – fosters a supportive, high-expectation environment.
- **Diversity & inclusion**: Employee Resource Groups (ERGs) actively promote belonging; DEI is integral to the company’s DNA [springworkstx.com](https://springworkstx.com/careers/).
- **Professional growth**: Stretch opportunities, mentorship from smart colleagues, and a chance to help build a company within a larger global pharma (Merck KGaA).
- **Benefits**: Competitive compensation, benefits, and the chance to work on therapies that are first-in-class or best-in-class.
- **Work policy**: Not explicitly stated, but the company has offices in Stamford, CT, and roles across the U.S. and Europe; likely hybrid/office for commercial and lab roles.
- **Headcount**: ~302 employees; recently acquired by Merck, so stability is high but integration may bring changes.

## Sources
1. [springworkstx.com](https://springworkstx.com/) – Company overview, pipeline, news
2. [springworkstx.com](https://springworkstx.com/who-we-are/) – About Us, mission, values
3. [springworkstx.com](https://springworkstx.com/careers/) – Careers page, culture, benefits
4. [springworkstx.com](https://springworkstx.com/pipeline/) – Pipeline details, collaborations
5. [linkedin.com](https://www.linkedin.com/company/springworks-therapeutics) – Employee count, revenue, funding, market cap, acquisition details

## Other roles at SpringWorks Therapeutics

- [Territory Business Manager - Detroit (OGSIVEO)](https://feeny.ai/job/territory-business-manager-detroit-ogsiveo-springworks-therapeutics-detroit-mi-f4ss3f5sq37k) — / Detroit MI, United States
- [Regional Marketing Lead - NF1-PN (Southeast)](https://feeny.ai/job/regional-marketing-lead-nf1-pn-southeast-springworks-therapeutics-y6ce45r9j76g) — /, United States
- [Regional Marketing Lead - NF1-PN (Northeast)](https://feeny.ai/job/regional-marketing-lead-nf1-pn-northeast-springworks-therapeutics-p3cs6dy5rrgs) — /, United States
- [Territory Business Manager - San Francisco (OGSIVEO)](https://feeny.ai/job/territory-business-manager-san-francisco-ogsiveo-springworks-therapeutics-san-2t42ft4j045e) — / San Francisco CA, United States
- [Territory Business Manager - Chicago (GOMEKLI)](https://feeny.ai/job/territory-business-manager-chicago-gomekli-springworks-therapeutics-chicago-jq8b1vt8329d) — / Chicago Illinois, United States
- [Territory Business Manager - San Francisco (GOMEKLI)](https://feeny.ai/job/territory-business-manager-san-francisco-gomekli-springworks-therapeutics-san-yzajfm6fthtx) — / San Francisco CA, United States
- [Director, Value, Access Strategy, and Payer Marketing (GOMEKLI)](https://feeny.ai/job/director-value-access-strategy-and-payer-marketing-gomekli-springworks-2tywycqw7e6b) — /, United States
- [Territory Business Manager - Milwaukee (GOMEKLI)](https://feeny.ai/job/territory-business-manager-milwaukee-gomekli-springworks-therapeutics-milwaukee-b49p3n8mz7q6) — / Milwaukee Wisconsin, United States
- [Executive Director, Brand Lead U.S. NF1-PN Marketing](https://feeny.ai/job/executive-director-brand-lead-u-s-nf1-pn-marketing-springworks-therapeutics-2zq2kw3b3prr) — / Boston MA, United States
- [Senior Director, Digital & Omnichannel Strategy](https://feeny.ai/job/senior-director-digital-omnichannel-strategy-springworks-therapeutics-boston-ma-jm6szee7haev) — / Boston MA, United States